✦ LIBER ✦

Systemic chemotherapy for advanced breast cancer

✍ Scribed by Alfred A. Fracchia; Joseph H. Farrow; Yehuda G. Adam; Jorge Monroy; William H. Knapper

Publisher: John Wiley and Sons
Year: 1970
Tongue: English
Weight: 623 KB
Volume: 26
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(197009)26:3<642::aid-cncr2820260323>3.0.co;2-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Primary systemic chemotherapy for inflam

Primary systemic chemotherapy for inflammatory breast cancer

✍ Sarah Sinclair; Sandra M. Swain 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB

## Abstract The advent of multimodality therapy for patients with inflammatory breast cancer (IBC), consisting of neoadjuvant chemotherapy, particularly taxanes, surgery, radiotherapy, and hormonal therapy, has improved survival. A pathologic complete response to neoadjuvant chemotherapy in locally

Secondary chemotherapy of advanced breas

Secondary chemotherapy of advanced breast cancer

✍ Ira S. Goldenberg; C. A. McMahan; George C. Escher; Herbert Volk; Fred J. Ansfie 📂 Article 📅 1973 🏛 John Wiley and Sons 🌐 English ⚖ 255 KB 👁 2 views

Mitomycin C and vinblastine chemotherapy

Mitomycin C and vinblastine chemotherapy for advanced breast cancer

✍ P. H. Konits; J. Aisner; D. A. Van Echo; K. Lichtenfeld; P. H. Wiernik 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 395 KB 👁 2 views

Neoadjuvant chemotherapy in locally adva

Neoadjuvant chemotherapy in locally advanced breast cancer

✍ Singh, Gurpreet; Singh, Deepinder P.; Gupta, Devender; Muralikrishna, Bhavaraju 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 403 KB 👁 2 views

Thirty-eight patients with locally advanced breast cancer (Stage HI) were treated over a 3-year period. All patients initially received two cycles of CMF (cyclophosphamide, 100 mg/m2 p.0. dl-14; methotrexate 40mg/m2 intravenously (iv), d l and d8., 5 Fluorouracil 500 mg/m2 iv d l and d8). They were

Combination chemotherapy for advanced br

Combination chemotherapy for advanced breast cancer. Two regimens containing adriamycin

✍ Gerard T. Kennealey; Barry Boston; Malcolm S. Mitchell; Mary Kathryn Knobf; Samu 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 518 KB

Forty-eight women with advanced metastatic carcinoma of the breast were treated with one of two combination chemotherapy regimens: 1) adriamycin and cyclophosphamide or 2) adriamycin, cyclophosphamide, methotrexate and 5-fluorouracil. The response rate in the two-drug treatment group was 50% and in

Combination chemotherapy with adriamycin

Combination chemotherapy with adriamycin and cyclophosphamide for advanced breast cancer

✍ Stephen E. Jones; Brian G. M. Durie; Sydney E. Salmon 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 622 KB